Literature DB >> 16457124

13C-octanoic acid breath test in functional and organic disease: critical review of literature.

P Usai Satta1, M Scarpa, F Oppia, F Loriga.   

Abstract

The 13C-octanoic acid breath test is considered a useful tool to measure gastric emptying both in physiological and pathological conditions. Many studies have concerned functional dyspepsia. Recently, breath test has been used in predicting a delayed gastric emptying in subsets of dyspeptic symptoms. In detail only postprandial fullness and vomiting are resulted significantly correlated with delayed solid emptying. Besides in the patients with dyspepsia and irritable bowel syndrome associated, intestinal disturbances did not seem to contribute to delay gastric emptying. In diabetic patients octanoate test has confirmed the percentages of delayed emptying obtained by means of scintigraphy. In other organic states (celiac disease, cirrhosis, renal failure, neurological disease, etc) most of reports have proved a delayed emptying of solids. In GERD and ulcer disease gastric function is resulted normal, being accelerated in distal gastrectomy and in hyperemesis gravidarum. From pathophysiological point of view Helicobacter pylori, extrinsic autonomic neuropathy (apart from diabetes) and autoimmunity do not seem to relate with gastric emptying, both in functional and organic disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16457124

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  2 in total

1.  Electroacupuncture combined with mosapride alleviates symptoms in diabetic patients with gastroparesis.

Authors:  Wenping Pan; Zhankui Wang; Feilong Tian; Mingxian Yan; Yan Lu
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447

Review 2.  Gastroparesis: New insights into an old disease.

Authors:  Paolo Usai-Satta; Massimo Bellini; Olivia Morelli; Francesca Geri; Mariantonia Lai; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2020-05-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.